Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Assay:
≥98% (HPLC)
Form:
powder
Storage condition:
desiccated
Quality Segment
assay
≥98% (HPLC)
form
powder
storage condition
desiccated
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
-10 to -25°C
Application
Biochem/physiol Actions
Crinecerfont HCl exhibits nanomolar affinity (Kᵢ ~ 0.8-1.8 nM) for CRF1 receptors across human recombinant (hCRF1-CHO cells, pKᵢ = 8.73) , human native (Y79 cells, pKᵢ = 9.08), rat (pKᵢ = 8.77), mouse (pKᵢ = 8.90), and gerbil (pKᵢ = 9.00) brain tissues, while demonstrating a >1,000-fold selectivity against CRF2a receptors and CRF binding protein. Functionally, Crinecerfont’s mechanism of action is through the CRF1 receptor, modulating the cAMP pathway, and competitively inhibiting CRF-induced cAMP production (IC50 = 3.0 nM) in human retinoblastoma Y79 cells and CRF-stimulated adrenocorticotropic hormone (ACTH) secretion in mouse pituitary AtT-20 cells, without displaying any intrinsic agonist activity, demonstrating a highly selective inhibition of CRF1 receptor function. Furthermore, Crinecerfont also influences the cholinergic and noradrenergic systems, reducing hippocampal acetylcholine release and cortical norepinephrine release in rats under stress conditions.
Disclaimer
Hygroscopic Store with desiccant
Storage Class
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.